Labio-Jugal Squamous Cell Carcinoma on HIV Site: Surgical Excision and Reconstruction with a Musculocutaneous Flap of the Pectoralis Major: A Case Report
Introduction: Malignant skin tumors are very frequent lesions, induced by sustained sun exposure. Cutaneous squamous cell carcinoma is a dangerous cancer of the skin. It’s more frequent in white people than black people. Squamous cell carcinomas sometimes pose a real problem of local reconstruction after their removal. Reconstructions may involve the production of regional pedunculated flaps to repair the loss of substance. We report the case of a labio-jugal squamous cell carcinoma in an HIV-positive patient. The excision of the tumor required repair by a musculocutaneous flap of the pectoralis major. The aim of this paper is to show the dangerousness of that cancer, the particularity of its location around the mouth. We also want to call for a reflection about the recurrence of that disease on HIV infection ground, despite correct resection. Clinical Case: This was a 47-year-old HIV-positive patient on antiretroviral therapy (ARVs), treated 23 years ago for pulmonary tuberculosis. He presented with an ulcerated lower lip wound extending to the right labial commissure, right cheek, and the right lateral third of the upper lip. This lesion had progressed for about 6 months without a tendency to spontaneous healing. There was no palpable lymphadenopathy, especially in the cervicofacial region. The biopsy of the lower labial lesion concluded that it was a differentiated, mature, infiltrating squamous cell carcinoma. The craniofacial CT scan did not note any regional tumor invasion. We indicated tumor excision, functional lymph node dissection, and reconstruction by a flap of the pectoralis major muscle. The operative procedure was performed under general anesthesia. The edge cuts after carcinoma removal were healthy. Three months later, the patient is seen again with a local right submandibular recurrence. Radiotherapy was offered to him. Discussion: Squamous cell carcinomas are frequent in sub-Saharan Africa with preferential localization to oropharynx and oral cavity. More and more viral infections such as HIV, HBV and HCV are implicated in the occurrence of squamous cell carcinomas of the ENT and neck and facial sphere. HIV appears to be a contributing factor in young populations. Multidisciplinary management with anti-infective treatment coupled with new therapies could reduce the risk of recurrence and metastases.
References
[1]
Saka, B., Akakpo, S.A., Teclessou, J.N., Gnossike, P., Adam, S., Mahamadou, G., Kassang, P., Elegbede, Y., Mouhari-Toure, A., Kombate, K. and Pitché, P. (2021) Skin Cancers in People with Albinism in Togo in 2019: Results of Two Rounds of National Mobile Skin Care Clinics. BMC Cancer, 21, 26. https://doi.org/10.1186/s12885-020-07747-8
[2]
Zhang, H., Kim, S., Chen, Z., et al. (2017) Prognostic Biomarkers in Patients with Human Immunodeficiency Virus-Positive Disease with Head and Neck Squamous Cell Carcinoma. Head & Neck, 39, 2433-2443. https://doi.org/10.1002/hed.24911
[3]
Sami, A., Elimairi, I., Stanton, C., Ross, R.P. and Ryan, C.A. (2020) The Role of the Microbiome in Oral Squamous Cell Carcinoma with Insight into the Microbiome-Treatment Axis. International Journal of Molecular Sciences, 21, 8061. https://doi.org/10.3390/ijms21218061
[4]
Faggons, C.E., Mabedi, C., Shores, C.G., Gopal, S. (2015) Review: Head and Neck Squamous Cell Carcinoma in Sub-Saharan Africa. Malawi Medical Journal, 27, 79-87. https://doi.org/10.4314/mmj.v27i3.2
[5]
Saka, B., Téclessou, J., Akakpo, S., Gnossiké, P., Doh, K., Adam, S., Mouhari-Touré, A., Garba, M., Kombaté, K. and Pitché, P. (2020) Histopathological Study of Skin Lesions in Individuals with Oculocutaneous Albinism in Togo in 2019. Journal of Skin Cancer, 2020, Article ID: 2361957. https://doi.org/10.1155/2020/2361957
[6]
Nayyar, S.S., Thiagarajan, S., Malik, A., et al. (2020) Head and Neck Squamous Cell Carcinoma in HIV, HBV and HCV Seropositive Patients—Prognosis and Its Predictors. Journal of Cancer Research and Therapeutics, 16, 619-623. https://doi.org/10.4103/jcrt.JCRT_166_19
[7]
Picard, A., Arowas, L., Piroth, L., et al. (2018) Head and Neck Squamous Cell Carcinoma in People Living with HIV in France. Médecine et Maladies Infectieuses, 48, 503-508. https://doi.org/10.1016/j.medmal.2018.05.002
[8]
Butt, F.M.A., Chindia, M.L. and Rana, F. (2012) Oral Squamous Cell Carcinoma in Human Immunodeficiency Virus Positive Patients: Clinicopathological Audit. The Journal of Laryngology & Otology, 126, 276-278. https://doi.org/10.1017/S0022215111002647
[9]
Ceccarelli, M., Rullo, E.V., Facciolà, A., et al. (2018) Head and Neck Squamous Cell Carcinoma and Its Correlation with Human Papillomavirus in People Living with HIV: A Systematic Review. Oncotarget, 9, 17171-17180. https://doi.org/10.18632/oncotarget.24660
[10]
Cohen, E.E.W., Bell, R.B., Bifulco, C.B., et al. (2019) The Society for Immunotherapy of Cancer Consensus Statement on Immunotherapy for the Treatment of Squamous Cell Carcinoma of the Head and Neck (HNSCC). Journal for Immunotherapy of Cancer, 7, 184. https://doi.org/10.1186/s40425-019-0662-5
[11]
Schoenfeld, J.D., Hanna, G.J., Jo, V.Y., et al. (2020) Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial. JAMA Oncology, 6, 1563-1570. https://doi.org/10.1001/jamaoncol.2020.2955
[12]
Solomon, B., Young, R.J. and Rischin, D. (2018) Head and Neck Squamous Cell Carcinoma: Genomics and Emerging Biomarkers for Immunomodulatory Cancer Treatments. Seminars in Cancer Biology, 52, 228-240. https://doi.org/10.1016/j.semcancer.2018.01.008
[13]
Kuan, E.C., Clair, J.M.-S., Badran, K.W., et al. (2016) How Does Depth of Invasion Influence the Decision to Do a Neck Dissection in Clinically N0 Oral Cavity Cancer? Laryngoscope, 126, 5476. https://doi.org/10.1002/lary.25707
[14]
González-García, R., Naval-Gías, L., Rodríguez-Campo, F.J., et al. (2008) Contralateral Lymph Neck Node Metastasis of Squamous Cell Carcinoma of the Oral Cavity: A Retrospective Analytic Study in 315 Patients. Journal of Oral and Maxillofacial Surgery, 66, 1390-1398. https://doi.org/10.1016/j.joms.2008.01.012
[15]
Yao, C.M.K.L., Chang, E.I., Lai, S.Y., et al. (2019) Contemporary Approach to Locally Advanced Oral Cavity Squamous Cell Carcinoma. Current Oncology Reports, 21, 99. https://doi.org/10.1007/s11912-019-0845-8
[16]
Maruo, T., Zenda, S. and Shinozaki, T. (2020) Comparison of Salvage Surgery for Recurrent or Residual Head and Neck Squamous Cell Carcinoma. Japanese Journal of Clinical Oncology, 50, 288-295. https://doi.org/10.1093/jjco/hyz176
[17]
Hsiang, C.-C., Chen, A.W.-G., Chen, C.-H., et al. (2019) Early Postoperative Oral Exercise Improves Swallowing Function among Patients with Oral Cavity Cancer: A Randomized Controlled Trial. Ear, Nose & Throat Journal, 98, E73-E80. https://doi.org/10.1177/0145561319839822
[18]
Thomson, P.J. (2018) Perspectives on Oral Squamous Cell Carcinoma Prevention— Proliferation, Position, Progression and Prediction. Journal of Oral Pathology & Medicine, 47, 803-807. https://doi.org/10.1111/jop.12733
[19]
Tumban, E. (2019) A Current Update on Human Papillomavirus-Associated Head and Neck Cancers. Viruses, 11, 922. https://doi.org/10.3390/v11100922
[20]
Gao, F., Yin, P., Wu, Y., et al. (2021) Knockdown of RhoC Inhibits Oral Squamous Cell Carcinoma Cell Invasion and Metastasis via Regulation of HMGA2. Journal of Oncology, 1-12. https://doi.org/10.1155/2021/6644077